Why Moderna Stock Rallied Today
Copyright 1995-2022 The Motley Fool. All rights reserved.
finance
2022-10-21 21:54:09

Shares of Moderna (MRNA 8.40%) jumped 8.4% on Friday after rival drugmaker Pfizer (PFE 4.75%) said it intends to drastically increase the price of its COVID-19 vaccine next year. So what
Pfizer is seeking to charge as much as $130 per dose, up from the $30.50 per shot it currently receives from the U.S. government. The pharmaceutical giant is currently in talks with health insurers to determine the final price of the drug, according to The Wall Street Journal. 
The news gave investors better insight into the potential revenue vaccine makers could generate once the industry transitions from a public-health emergency to a commercial market for COVID-19 drugs.
